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activitiesAbstract A variety of different novel functionalized ferrocenyl chalcone and organic chalcone
based sulfones and bis-sulfones were synthesized in excellent yield under mild reaction condition.
The antimicrobial activities as bactericide and fungicide were evaluated for all the synthesized
compounds and structure–activity relationships were established. Many compounds exhibited high
and broad-range bactericidal activity. Among them, organic chalcone based on nitro-substituted 4c
and chloro-substituted 6c, ferrocenyl chalcone based trimethoxy-substituted 20c and dimethyl-
substituted 24c molecules displayed the best and broad-range bactericidal activity. Product 24c also
exhibited the highest antifungal activity against most of the fungi tested. In fact some compounds
are more potent and some are comparable with standard drugs.
ª 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Despite advances in the multimodal management of a wide
spectrum of human microbial infections, it remains life-threat-
ening along with the drug-resistant bacterial and fungal strains
globally, highlighting the need for the development of new
drugs. Interestingly, nature has proven to be one of the best
sources of molecules that can help in the prevention and thetreatment (Belofsky et al., 2004; Lin and Lee, 2012). Therefore,
the search for the novel natural molecules, semi-synthetic and
synthetic molecules that display fast-acting and broad-spec-
trum antimicrobial activity against bacteria and fungi is of
great interest for the scientiﬁc community and the pharmaceu-
tical industry (Ceylan et al., 2011; Karaman et al., 2012).
Chalcones, a sub-class of ﬂavonoids are widely distributed
as secondary metabolites in plant kingdom. They are reported
for various biological activities such as antimicrobial, anti-
inﬂammatory, anti-malarial, anti-leishmanial, antioxidant
and antitubercular (Ahmed et al., 2014; Prasad et al., 2008;
Wu et al., 2002; Lin et al., 2002). Substitutions on chalcone
moieties have shown enhanced biological activities. For
example, pyrimidinyl substitution on chalcone displayed high
antitumor property (Jin et al., 2013), quinolone substitution
on chalcone exhibited great antimalarial activity (Li et al.,and bis-
2 N. Ahmed et al.1995), and thiophenol addition on chalcone showed potent
anti-breast cancer property (Kumar et al., 2011).
Similarly, the sulﬁde and sulfone substituted organic mole-
cules are found useful precursors in organic synthesis and the
biologically relevant compounds (Alba et al., 2010; Simpkins,
1993; Patai et al., 1988; Backvall et al., 1998; Carreno, 1995;
Frenanez and Khiar, 2003). The sulfonyl group has electron
withdrawing property and hence stabilizes carbanion interme-
diates during the reaction (Najera and Sansano, 1998) and
have shown radical stabilizer (Paquette, 2001) and cationic
synthon properties during the reactions (Chinchilla and
Najera, 1997). In biology, the polar nature of sulfonyl group
enhanced lipophilicity (Buehrdel et al., 2009), and hence the
antimicrobial activity of the molecule (Caron et al., 1997).
For example, Penicillin G, methicillin, ampicillin, piperacillin
and sulfanilamide antimicrobial drugs have sulﬁde and sulfone
moieties (Saga and Yamaguchi, 2009). Moreover, compounds
possessing a para-substituted –SO2Me group on the phenyl
ring have shown inhibition of COX-activity (Talley, 1999).
Compounds such as 1,3-diphenylprop-2-yn-1-one (2) and
etoricoxib (4) exhibit selective COX-2 (cyclooxygenase-2)
inhibitory activity (Rao et al., 2005). Rofecoxib (1), a non-ste-
roidal anti-inﬂammatory drug (NSAID) is used in the treat-
ment of arthritis and other similar conditions causing
chronic or acute pain. Sulindac sulfone (3) is used in the treat-
ment of tumor and HCA-7 cells which led to inhibition of
prostaglandin E2 production (Fig. 1) (Williams et al., 1999).
The sulfur containing ferrocenyl compounds have displayed
important biological and pharmaceutical activities such as
antitumor, antimalarial, anti-microbial and DNA cleaving
properties (Ilic et al., 2012; Fourie et al., 2011). These com-
pounds remained a frontier research area (Arrayas et al.,
2006) in the development of novel materials (Patra et al.,
2011), catalysts for asymmetric conversion of aldehydes to
epoxides (Miniere et al., 2004). The synthesis of novel organic
sulfones is mainly reported via oxidation of sulﬁdes, which is
typically achieved using stoichiometric or catalytic amounts
of inorganic reagents (Choudary et al., 2002; Zali et al.,
2008; Kirihara et al., 2009). However, these reactions are slow
due to rapid decomposition of reactants and thus gave low
yield. Therefore, an extensive study has been undertaken toFigure 1 Natural and biologically active sulfone derivatives.
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Rezayan, 2007; Rahimi et al., 2009). Recently, we reported
some organic chalcone based sulfone synthesis where oxida-
tion of sulﬁde to sulfone has been optimized with m-CPBA
(meta-Chloroperbenzoic acid) in terms of molar ratio and reac-
tion conditions (Konduru et al., 2013). Our previous antimi-
crobial results (Konduru et al., 2013) encouraged to
synthesize the new class of sulfones and their evaluation for
antimicrobial activity. Following the reported method
(Konduru et al., 2013), a variety of novel ferrocenyl chalcone
based sulfones (17–24c), organic chalcone based sulfones (1–
4c, 5–8c, 13–16c) and bis-sulfones (9–12c) were synthesized
and evaluated for their antimicrobial properties.2. Materials and methods
2.1. General
All the required chemicals were purchased from Merck and
Aldrich Chemical Company. Pre-coated aluminum sheets
(silica gel 60 F254, Merck) were used for thin-layer chromatog-
raphy (TLC) and spots were visualized under UV light. High-
resolution mass spectra (HRMS) were recorded using Bruker
EI and ES-TOF mass spectrometers. Elemental analysis was
performed by using Perkin-Elmer 2400 series CHNS/O ana-
lyzer. IR spectra were recorded with KBr on Thermo Nicolet
FT-IR spectrophotometer. 1H NMR and 13C NMR spectra
were recorded respectively on Bruker Spectrospin DPX
500 MHz and Bruker Spectrospin DPX 125 MHz spectrome-
ter using CDCl3 as a solvent and trimethylsilane (TMS) as
an internal standard. Splitting patterns are designated as fol-
lows; s, singlet; d, doublet; and m, multiplet. Chemical shift
values are given in ppm.
2.2. General procedure for synthesis of compounds (1–8c)
To a stirred solution of chalcone sulﬁde (1 mmol) in dichloro-
methane was added m-CPBA (2.2 mmol, 379.5 mg) at 0 C
portion wise for 15 min and the reaction mixture stirred at this
temperature for 30 min, then warmed to room temperature
and stirred for appropriate time in Table 1. TLC monitoring,
the reaction was diluted with dichloromethane (8 mL) and
washed with 5% aqueous K2CO3 (3 · 8 mL) and 5% NaHCO3
(10 mL) solution for removing excess m-CPBA. Then, the
aqueous layer extracted with dichloromethane (3 · 10 mL),
the combined organic layers dried over anhydrous Na2SO4
and solvent evaporated in vacuo. Pure sulfone was obtained
by recrystallization from methanol.2.2.1. 1-(2-Hydroxyphenyl)-3-(4-methylphenyl)-3-
(phenylsufonyl)propan-1-one (1c)
Yield 90%; white solid; mp 155–157 C; 1H NMR (CDCl3,
500 MHz) d 11.61 (s, br, D20 exchangeable, 1H), 7.93–7.83
(m, 2H), 7.64–7.47 (m, 4H), 7.26–7.23 (m, 2H), 7.06–7.02 (m,
3H), 6.95–6.92 (m, 2H), 4.90 (dd, J= 9.5 Hz, 3.5 Hz, 1H),
4.13 (dd, J= 16 Hz, 3.5 Hz, 1H), 3.97–3.92 (m, 1H), 2.30 (s,
3H). 13C NMR (CDCl3, 125 MHz): 198.63, 161.38, 139.83,
136.25, 135.48, 132.02, 129.92, 129.64, 129.27, 128.81, 128.29,
127.93, 127.63, 126.21, 116.22, 62.94, 37.22, 21.28. IR (KBr):
3438, 3067, 2997, 2952, 1707, 1543, 1315, 1154, 761 cm1.bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
14.12.008
‘‘Activities of novel ferrocenyl and chalcone based sulfones and bis-sulfones’’ 3HR-MS (ESIMS) for C22H21O4S (M+ H)
+ Anal. calcd.
381.1161; found 381.1169. CHNS: Anal. calcd. for
C22H20O4S; C, 69.45; H, 5.30; S, 8.43. Found: C, 69.55; H,
5.21; S, 8.29.
2.2.2. 1-(2-Hydroxyphenyl)-3-(4-chlorophenyl)-3-
(phenylsufonyl)propan-1-one (2c)
Yield 95%; white solid; mp 165–167 C; 1H NMR (CDCl3,
500 MHz) d 11.63 (s, br, D20 exchangeable, 1H), 7.96 (d,
J= 8 Hz, 1H), 7.83 (d, J= 8 Hz, 1H), 7.60–7.57 (m, 3H),
7.43–7.4 (m, 3H), 7.16 (dd, J= 13 Hz, 8 Hz, 3H), 6.96–6.93
(m, 2H), 4.89 (dd, J= 18 Hz, 3 Hz, 1H), 4.16 (dd,
J= 18 Hz, 3 Hz, 1H), 3.94–3.89 (m, 1H). 13C NMR (CDCl3,
125 MHz): 199.24, 160.54, 138.74, 136.14, 133.14, 131.35,
130.14, 129.81, 129.07, 128.64, 128.05, 127.99, 127.43, 125.74,
115.98, 64.43, 37.22. IR (KBr): 3438, 3067, 2997, 2952, 1707,
1543, 1154, 761 cm1. HR-MS (ESIMS) for C21H18ClO4S
(M+H)+. Anal. calcd. 401.0614; found 401.0625. CHNS:
Anal. calcd. for C21H17ClO4S; C, 62.92; H, 4.27; S, 8.00.
Found: C, 62.86; H, 4.21; S, 7.84.
2.2.3. 1-(2-Hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)-3-
(phenylsufonyl)propan-1-one (3c)
Yield 91%; white solid; mp 121–122 C; 1H NMR (CDCl3,
500 MHz) d 12.10 (s, br, D20 exchangeable, 1H), 7.70 (dd,
J= 8 Hz, 1.5 Hz, 1H), 7.42–7.38 (m, 2H), 7.26–7.23 (m,
3H), 6.95 (d, J= 8.5 Hz, 1H), 6.9 (t, J= 7.5 Hz, 1H), 6.6 (s,
2H), 5.0 (dd, J= 16 Hz, 3 Hz, 1H), 3.8 (s, 3H), 3.78 (s, 6H),
3.7 (m, 1H), 3.68 (m, 1H). 13C NMR (CDCl3,
125 MHz):200.01, 161.64, 151.43, 139.84, 136.76, 135.47,
134.28, 131.54, 130.58, 129.67, 128.53, 122.58, 116.29, 105.94,
65.47, 56.64, 56.13, 38.24. IR (KBr): 3412, 3019, 2967, 1701,
1355, 1206. HR-MS (ESIMS) for C24H25O7S (M+ H)
+ Anal.
calcd 457.1321; found 457.1336. CHNS: Anal. calcd. for
C24H24O7S; C, 63.14; H, 5.30; S, 7.02. Found: C, 63.29; H,
5.26; S, 7.34.
2.2.4. 1-(2-Hydroxyphenyl)-3-(3-nitrophenyl)-3-
(phenylsufonyl)propan-1-one (4c)
Yield 92%; white solid; mp 121–123 C; 1H NMR (CDCl3,
500 MHz) d 12.10 (s, br, D20 exchangeable, 1H), 8.2 (s, 1H),
7.66–7.43 (m, 6H), 7.4–7.01 (m, 4H), 6.72 (d, J= 8 Hz, 1H),
5.05 (m, 1H), 3.82–3.78 (m, 1H), 3.76–3.72 (m, 1H). 13C
NMR (CDCl3, 125 MHz): 200.11, 160.54, 149.84, 140.24,
138.76, 135.64, 133.84, 132.24, 130.54, 129.21, 129.01, 128.75,
128.60, 128.10, 122.68, 119.64, 116.58, 63.54, 36.95. IR
(KBr): 3412, 3019, 2967, 1701, 1355, 1206. HR-MS (ESIMS)
for C21H17NNaO6S (M+Na)
+ Anal. calcd 434.0674; found
434.0665. CHNS: Anal. calcd. for C21H17NO6S; C, 61.30; H,
4.16; N, 3.40; S, 7.79. Found: C, 61.18; H, 4.09; N, 3.43; S,
7.88.
2.2.5. 1-(2-Aminophenyl)-3-(4-methylphenyl)-3-
(phenylsufonyl)propan-1-one (5c)
Yield 94%; white solid; mp 152–153 C; 1H NMR (CDCl3,
500 MHz) d 7.82 (d, J= 8 Hz, 1H), 7.44–7.30 (m, 1H), 6.52
(d, J= 8 Hz, 1H), 6.5 (s, br, D20 exchangeable, 2H), 5.04–
498 (m, 1H), 3.72–3.69 (m, 1H), 3.68 (m, 1H), 2.3 (s, 3H).
13C NMR (CDCl3, 125 MHz): 199.01, 150.67, 138.55, 137.01,
134.58, 132.51, 13.02, 130.73, 129.35, 129.26, 129.04, 127.88,Please cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
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3318, 3175, 2985, 2872, 1679, 1647, 1176, 748. HR-MS
(ESIMS) for C22H22NO3S (M+ H)
+ Anal. calcd 380.1320;
found 380.1327. CHNS: Anal. calcd. for C22H21NO3S; C,
69.63; H, 5.58; N, 3.69; S, 8.45. Found: C, 69.76; H, 5.44; N,
3.76; S, 8.25.
2.2.6. 1-(2-Aminophenyl)-3-(4-chlorophenyl)-3-
(phenylsufonyl)propan-1-one (6c)
Yield 95%; white solid; mp 163–165 C; 1H NMR (CDCl3,
500 MHz) d 7.84 (dd, J= 8 Hz, 1H), 7.66–7.3 (m, 11 Hz),
6.69–6.17 (m, 1H), 6.3 (s, br, D20 exchangeable, 2H), 4.95–
4.86 (m, 1H), 3.68–3.64 (m, 2H). 13C NMR (CDCl3,
125 MHz):198.46, 150.73, 140.43, 135.31, 134.27, 132.98,
130.99, 130.72, 129.27, 129.18, 127.87, 127.28, 117.69, 115.95,
68.65, 40.46. IR (KBr): 3415, 3317, 3015, 2984, 1686, 1175,
1267, 741. HR-MS (ESIMS) for C21H19ClNO3S (M+ H)
+
Anal. Calcd 400.0774; found 400.0770. CHNS: Anal. calcd.
for C21H18ClNO3S; C, 63.07; H, 4.54; N, 3.50; S, 8.02. Found:
C, 63.24; H, 4.49; N, 3.30; S, 8.31.
2.2.7. 1-(2-Aminophenyl)-3-phenyl-3-(phenylsulfonyl)propan-
1-one (7c)
Yield 93%; white solid; mp 135–136 C; 1H NMR (CDCl3,
500 MHz) d 7.65 (d, J= 8 Hz, 1H), 7.45–7.40 (m, 3H), 7.33–
7.18 (m, 8H), 6.58–6.5 (m, 1H), 6.40 (s, br, D20 exchangeable,
2H), 4.97 (m, 1H), 3.59–3.56 (m, 1H). 13C NMR (CDCl3,
125 MHz): 13C NMR (CDCl3, 125 MHz): 198.36, 150.27,
140.98, 135.99, 134.73, 132.46, 130.31, 130.65, 129.95, 129.28,
127.87, 127.18, 117.69, 115.27, 68.72, 40.43. IR (KBr): 3418,
3328, 3075, 2978, 2872, 1679, 1648, 1206, 756. HR-MS
(ESIMS) for C21H19NNaO3S (M+ Na)
+ Anal. Calcd
388.0983; found 388.0994. CHNS: Anal. calcd. for C21H19-
NO3S; C, 69.02; H, 5.24; N, 3.83; S, 8.77. Found: C, 69.16;
H, 5.22; N, 3.85; S, 8.65.
2.2.8. 1-(2-Aminophenyl)-3-(3-nitrophenyl)-3-
(phenylsufonyl)propan-1-one (8c)
Yield 91%; white solid; mp 220–222 C; 1H NMR (CDCl3,
500 MHz) d 8.02 (s, 1H), 7.79–7.71 (m, 4H), 7.67–7.51 (m,
3H), 7.45–7.42 (m, 2H), 6.69–6.59 (m, 2H), 6.12 (s, br, D20
exchangeable, 2H), 5.0 (m, 1H), 4.13 (m, 1H), 3.9 (m, 1H).
13C NMR (CDCl3, 125 MHz): 200.11, 150.64, 149.32, 140.15,
139.67, 135.21, 135.02, 134.54, 134.22, 130.21, 129.52, 129.10,
128.67, 124.88, 119.81, 119.00, 116.54, 63.41, 38.01. IR
(KBr): 3416, 3308, 3070, 2925, 2852, 1724, 1647, 1612, 1533,
1141, 746. HR-MS (ESIMS) for C21H19N2O5S (M+H)
+
Anal. Calcd 411.1015; found 411.1032. CHNS: Anal. calcd.
for C21H18N2O5S; C, 61.45; H, 4.42; N, 6.83; S, 7.81. Found:
C, 61.59; H, 4.39; N, 6.88; S, 7.70.
2.3. General procedure for synthesis of compounds (9–12c)
To a stirred solution of chalcone sulﬁde (1 mmol) in dichloro-
methane was added m-CPBA (4.5 mmol, 776.5 mg) at 0 C
portion wise for 25 min and the reaction mixture stirred at this
temperature for 30 min then warmed to room temperature and
stirred appropriate time in Table 2. TLC monitoring, the reac-
tion was diluted with dichloromethane (8 mL) and washed
with 5% aqueous K2CO3 (3 · 8 mL) and NaHCO3 (10 mL)bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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Table 1 Synthesis of 20-hydroxy- and 20-aminochalcone based sulﬁdes and sulfones.
Entry Chalcone Reaction
time (h)
Yields (%) Sulﬁde Reaction
time (h)
Yields (%) Amino/Hydroxy sulfone
1 1.5 90 3 90
2 1.5 92 4 95
3 2 90 3.5 91
4 2 93 3 92
5 2.5 90 2.5 94
6 3 95 3 95
7 3 91 3.5 93
8 2 92 3 91
4 N. Ahmed et al.
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Table 2 Synthesis of 1-(4-(methylsulfonyl) phenyl)-3-aryl-3-(phenylsulfonyl) propan-1-ones.
Entry Chalcone Reaction
time (min)
Yields (%) Bis-sulﬁde Reaction
time (min)
Yields (%) Bis-sulfone
9 20 95 20 95
10 20 96 20 96
11 20 94 20 91
12 20 95 20 92
‘‘Activities of novel ferrocenyl and chalcone based sulfones and bis-sulfones’’ 5solution for removing excess m-CPBA. Then, the aqueous
layer extracted with dichloromethane (3 · 10 mL), the com-
bined organic layers dried over anhydrous Na2SO4 and solvent
evaporated in vacuo. Pure sulfone was obtained by recrystalli-
zation from methanol.
2.3.1. 1-[4-(methylsulfonyl)phenyl]-3(4-chlorophenyl)-3-
(phenylsulfonyl)propan-1-one (9c)
Yield 95%; white solid; mp 124–126 C; 1H NMR (CDCl3,
500 MHz) d 7.86 (d, J= 8.5 Hz, 2H), 7.54 (dd, J= 8 Hz,
2 Hz, 3H), 7.42–7.38 (m, 3H), 7.28–7.22 (m, 5H), 4.99 (dd,
J= 8.5 Hz, 6 Hz, 1H), 3.63–3.61 (m, 1H), 3.59–3.56 (m,
1H), 3.01 (s, 3H). 13C NMR (CDCl3, 125 MHz): 195.66,
146.49, 139.88, 133.73, 132.98, 132.84, 129.18, 128.97, 128.60,
128.47, 127.82, 124.98, 99.99, 63.84, 44.25, 37.68. IR (KBr):
3131, 2979, 2921, 1653, 1589, 1401, 1303, 1057, 740. HR-MS
(ESIMS) for C22H19ClNaO5S2 (M+ Na)
+ Anal. Calcd
485.0260; found 485.0257. CHNS: Anal. calcd. for
C22H19ClO5S2; C, 57.07; H, 4.14; S, 13.85. Found: C,
57.25; H, 4.11; S, 13.67.
2.3.2. 1-[4-(methylsulfonyl)phenyl]-3(3-nitrophenyl)-3-
(phenylsulfonyl)propan-1-one (10c)
Yield 96%; white solid; mp 152–153 C; 1H NMR (CDCl3,
500 MHz) d 8.18 (s, 1H), 8.10 (d, J= 8 Hz, 1H), 7.9–7.85 (m,
2H), 7.68 (dd, J= 15 Hz, 4 Hz, 2H), 7.55–7.51 (m, 4H), 7.28–
7.23 (m, 3H), 4.98 (dd, J= 17.5 Hz, 4.5 Hz, 1H), 3.56–3.53
(m, 1H), 3.45–3.42 (m, 1H), 3.01 (s, 3H). 13C NMR (CDCl3,
125 MHz): 195.15, 146.87, 143.76, 134.31, 133.46, 132.83,Please cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
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99.99, 63.54, 44.65, 38.52. IR (KBr): 3418, 3328, 3075, 2978,
2872, 1679, 1648, 1206 cm1. HR-MS (ESIMS) for C22H19
NNaO3S2 (M+ Na)
+ Anal. Calcd 432.0704; found 432.0698.
CHNS: Anal. calcd. for C22H19NO7S2; C, 55.80; H, 4.04; N,
2.96; S, 13.54. Found: C, 55.56; H, 4.12; N, 3.00; S, 13.78.
2.3.3. 1-[4-(methylsulfonyl)phenyl]-3(4-methylphenyl)-3-
(phenylsulfonyl)propan-1-one (11c)
Yield 91%; white solid; mp 162–163 C; 1H NMR (CDCl3,
500 MHz) d 8.12 (dd, J= 8.5 Hz, 2 Hz, 1H), 8.06–8.02 (m,
2H), 7.97 (dd, J= 8.5 Hz, 1 Hz, 2H), 7.75–7.72(m, 3H),
7.42–7.39 (m, 2H), 7.03 (q, 3H), 4.88 (dd, J= 9.5 Hz, 4 Hz,
1H), 4.40–4.30 (m, 1H), 4.18 (dd, J= 18 Hz, 4 Hz, 1H),
3.89–3.83 (m, 1H), 3.10 (s, 3H), 2.27 (s, 3H). 13C NMR (CDCl3,
125 MHz): 196.13, 146.16, 138.11, 137.04, 132.94, 132.52,
130.74, 129.20, 129.04, 28.88, 128.52, 127.65, 127.41, 127.17,
124.92, 63.51, 44.34, 38.00, 21.14. IR (KBr): 3064, 2942,
2831, 1663, 1584, 1342, 1111, 781 cm1. HR-MS (ESIMS) for
C23H22NaO5S2 (M+ Na)
+ Anal. Calcd 465.0806; found
465.0811. CHNS: Anal. calcd. for C23H22O5S2; C, 62.42; H,
5.01; S, 14.49. Found: C, 62.34; H, 5.11; S, 14.22.
2.3.4. 1-(4-(methylsulfonyl)phenyl)-3-phenyl-3-
(phenylsulfonyl)propan-1-one (12c)
Yield 92%; white solid; mp 143–144 C; 1H NMR (CDCl3,
500 MHz) d8.10 (dd, J= 8 Hz, 1.5 Hz, 1H), 8.05–8.03 (m,
2H), 7.95 (dd, J= 8 Hz, 1.5 Hz, 2H), 7.62–7.59 (m, 3H),
7.41–7.38 (m, 2H), 7.0–6.56 (m, 3H), 4.96 (dd, J= 8.5 Hz,bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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6 N. Ahmed et al.3 Hz, 1H), 4.34–4.30 (m, 1H), 4.20–4.18 (m, 1H), 3.90–3.88 (m,
1H), 3.05 (s, 3H). 13CNMR (CDCl3, 125 MHz): 195.82, 147.32,
141.83, 131.92, 130.74, 130.02, 129.21, 128.69, 127.63, 127.14,
126.26, 124.74, 122.53, 65.52, 38.53, 44.65. IR (KBr): 3054,
2929, 2851, 1660, 1599, 1302, 1146, 756. HR-MS (ESIMS) for
C22H20NaO5S2 (M+ Na)
+ Anal. Calcd 451.0650; found
451.0661. CHNS: Anal. calcd. for C22H20O5S2; C, 61.66; H,
4.70; S, 14.97. Found: C, 61.75; H, 4.68; S, 14.78.
2.4. General procedure for synthesis of chalcone based sulfones
(13–16c)
To a stirred solution of chalcone sulﬁde (1 mmol) in dichloro-
methane was added m-CPBA (2.2 mmol, 379.5 mg) at 0 C
portion wise for 15 min and the reaction mixture stirred at this
temperature for 30 min then warmed to room temperature and
stirred for appropriate time in Table 3. TLC monitoring, the
reaction was diluted with dichloromethane (8 mL) and washed
with 5% aqueous K2CO3 (3 · 8 mL) and 5% NaHCO3
(10 mL) solution for removing excess m-CPBA. Then, the
aqueous layer extracted with dichloromethane (3 · 10 mL),
the combined organic layers dried over anhydrous Na2SO4
and solvent evaporated in vacuo. Pure sulfone was obtained
by recrystallization from methanol.
2.4.1. (E)-3-(4-chlorophenyl)-1-(4-
(methylsulfonyl)phenyl)prop-2-en-1-one (13c)
Yield 96%; White solid; mp 199–200 C; 1H NMR (CDCl3,
500 MHz) d 8.09 (d, J= 8.5 Hz, 2H), 8.02 (d, J= 8.5 Hz,Table 3 Synthesis of (E)-3-aryl-1-(4-(methylsulfonyl)phenyl)prop-2
Entry Chalcone Rxn.time (hr
14 3
15 3
16 3.5
17 3
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7.41–7.34 (m, 3H), 3.03 (s, 3H). 13C NMR (CDCl3,
125 MHz): 189.13, 145.15, 143.81, 142.30, 137.15, 132.78,
129.81, 129.41, 129.26, 127.83, 121.76, 44.36. IR (KBr): 3021,
2926, 1726, 1298, 1143. HR-MS (ESIMS) for C16H13ClO3NaS
(M+Na)+ Anal. Calcd 343.0172; found 343.0152. CHNS:
Anal. calcd. for C16H13ClO3S; C, 59.91; H, 4.08; S, 10.00.
Found: C, 59.86; H, 4.11; S, 10.21.
2.4.2. (E)-3-(3-nitrophenyl)-1-(4-
(methylsulfonyl)phenyl)prop-2-en-1-one (14c)
Yield 95%; White solid; mp 243–244 C; 1H NMR (CDCl3,
500 MHz) d 8.55 (s, 1H), 8.31–8.29 (m, 1H), 8.21–8.2 (dd,
J= 6.5 Hz, 2 Hz, 2H), 8.13 (dd, J= 7 Hz, 2 Hz, 2H), 7.95–
7.9 (m, 2H), 7.67–7.6 (m, 2H), 3.12 (s, 3H). 13C NMR (CDCl3,
125 MHz):189.65, 149.58, 146.83, 139.46, 138.53, 136.84,
134.93, 134.23, 132.02, 129.60, 122.84, 121.04, 44.75. IR
(KBr): 3011, 2985, 1698, 1534, 1443, 1268. HR-MS (ESIMS)
for C16H14NO5S (M+ H)
+ Anal. Calcd 332.0593; found
332.0600. CHNS: Anal. calcd. for C16H13NO5S; C, 58.00; H,
3.95; N, 4.23; S, 9.68. Found: C, 57.91; H, 3.91; N, 4.22; S, 9.60.
2.4.3. (E)-3-(4-methylphenyl)-1-(4-
(methylsulfonyl)phenyl)prop-2-en-1-one (15c)
Yield 96%; White solid; mp 160–162 C; 1H NMR (CDCl3,
500 MHz) d 8.07 (d, J= 3.5 Hz, 2H), 8.0 (d, J= 3.5 Hz,
2H), 7.74 (d, J= 15.5 Hz, 1H), 7.48 (d, J= 5 Hz, 2H), 7.36
(d, J= 16 Hz, 1H), 7.21–7.16 (m, 2H), 3.13 (s, 3H), 2.21 (s,
3H). 13C NMR (CDCl3, 125 MHz): 189.50, 146.81, 143.51,-en-1-one.
) Sulfone Yields (%)
96
95
96
98
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44.33, 21.56. IR (KBr): 3017, 2921, 1660, 1597. HR-MS
(ESIMS) for C17H17O3S (M+ H)
+ Anal. Calcd 301.0898;
found 301.0904. CHNS: Anal. calcd. for C17H16O3S; C,
67.98; H, 5.37; S, 10.68. Found: C, 67.87; H, 5.43; S, 10.82.
2.4.4. (E)-3-phenyl-1-(4-(methylsulfonyl)phenyl)prop-2-en-1-
one (16c)
Yield 98%; White solid; mp 168–170 C; 1H NMR (CDCl3,
500 MHz) d 8.08 (d, J= 8 Hz, 2H), 7.80 (d, J= 8 Hz, 2H),
7.75 (d, J= 16 Hz, 1H), 7.41–7.36 (m, 4H), 3.03 (s, 3H). 13C
NMR (CDCl3, 125 MHz): 188.12, 145.76, 143.54, 142.45,
141.62, 134.15, 130.42, 129.49, 128.27, 126.41, 120.36, 45.10.
IR (KBr): 3024, 2921, 1633, 1307, 1149. HR-MS (ESIMS)
for C16H14NaO3S (M+Na)
+ Anal. calcd 309.0561; found
309.0554. CHNS: Anal. calcd. for C16H14O3S; C, 67.11; H,
4.93; S, 11.20. Found: C, 67.23; H, 4.89; S, 11.34.
2.5. General procedure for synthesis of compounds (17c–24c)
In a ﬂame dried round bottom ﬂask was added ferrocenyl chal-
cone sulﬁde (1 mmol) and dissolved in dry dichloromethane
under N2 gas for 6 min. Then, m-CPBA (2.2 mmol,
379.5 mg) in dichloromethane was added at 0 C drop wise
for 15 min and the reaction mixture stirred at this temperature
for 30 min. then warmed to room temperature and stirred for
appropriate time in Table 4. TLC monitoring, the reaction was
diluted with dichloromethane (8 mL) and washed with 5%
aqueous K2CO3 (3 · 8 mL) and 5% NaHCO3 (10 mL) solu-
tion for removing excess m-CPBA. Then, the aqueous layer
extracted with dichloromethane (3 · 10 mL), the combined
organic layers dried over anhydrous Na2SO4 and solvent evap-
orated in vacuo. Pure ferrocenyl sulfone was obtained by
recrystallization from methanol.
2.5.1. 1-(4-Chlorophenyl)-3-ferrocenyl-3-phenylsulfonylpropan-
1-one (17c)
Yield 92%; orange red solid; mp 147–148 C; 1H NMR
(CDCl3, 500 MHz) d 7.81 (d, J= 9 Hz, 2H), 7.45 (dd,
J= 9 Hz, 2.5 Hz, 2H), 7.32–7.30 (m, 2H), 7.25–7.20 (m,
3H), 4.98 (t, J= 6.5 Hz, 1H), 4.19–4.10 (m, 4H), 4.09 (s,
5H), 3.85–3.84 (m, 1H), 3.58 (dd, 18 Hz, 4 Hz, 1H), 13C
NMR (CDCl3, 125 MHz): 197.25, 138.14, 135.41, 134.24,
133.84, 131.54, 130.68, 129.38, 128.56, 81.21, 71.12, 70.15,
68.8, 67.9, 67.7, 66.9, 37.81. IR (KBr): 3021, 2954, 1702,
1463, 1401, 1298, 1108, 1156. HR-MS (ESIMS) for C25H22-
ClFeO3S (M+ H)
+ Anal. Calcd 493.0328; found 493.0321.
CHNS: Anal. calcd. for C25H21ClFeO3S; C, 60.93; H, 4.30;
S, 6.51. Found: C, 60.85; H, 4.29; S, 6.43.
2.5.2. 1-(4-Methylphenyl)-3-ferrocenyl-3-phenylsulfonylpropan-
1-one (18c)
Yield 91%; orange red solid; mp 152–153 C; 1H NMR
(CDCl3, 500 MHz) d 7.86 (d, J= 3.5 Hz, 2H), 7.42–7.40 (m,
2H), 7.30–7.24 (m, 5H), 5.06 (t, J= 7.5 Hz, 1H), 4.06–3.99
(m, 9H), 3.48–3.45 (m, 2H), 2.3 (s, 3H). 13C NMR (CDCl3,
125 MHz): 196.53, 145.28, 135.26, 134.21, 133.54, 130.41,
129.51, 128.82, 127.58, 70.15, 68.8, 68.4, 67.9, 67.7, 67.5,
67.0, 36.16, 20.91.IR (KBr): 3102, 2935, 1670, 1465,
1376 cm1. HR-MS (ESIMS) for C26H24FeNaO3SPlease cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
sulfones. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20(M +Na)+ Anal. Calcd 495.0693; found 495.0690. CHNS:
Anal. calcd. for C26H24FeO3S; C, 66.11; H, 5.12; S, 6.79.
Found: C, 66.25; H, 5.09; S, 6.72.
2.5.3. 1-(4-Methoxylphenyl)-3-ferrocenyl-3-
phenylsulfonylpropan-1-one (19c)
Yield 94%; orange red solid; mp 165–166 C; 1H NMR
(CDCl3, 500 MHz) d 7.92 (dd, J= 7 Hz, 2 Hz, 2H), 7.34–
7.31 (m, 2H), 7.22–7.18 (m, 3H), 6.95 (dd, J= 7 Hz, 2 Hz,
2H), 5.06 (t, J= 7.5 Hz, 1H), 4.15–4.06 (m, 9H), 3.99 (s,
3H), 3.48–3.45 (m, 2H). 13C NMR (CDCl3, 125 MHz):
199.54, 163.64, 134.31, 131.94, 130.51, 129.14, 128.37, 126.66,
114.17, 89.0, 67.78, 66.8, 66.6, 65.9, 63.51, 37.41. IR (KBr):
3060, 2919, 2843, 1679, 1489, 1404, 1325, 1142, 1010,
865 cm1. HR-MS (ESIMS) for C26H25FeO4S (M+H)
+
Anal. Calcd 489.0823; found 489.0812. CHNS: Anal. calcd.
for C26H24FeO4S; C, 63.94; H, 4.95; S, 6.57. Found: C,
63.99; H, 4.99; S, 6.69.
2.5.4. 1-(3,4,5-Trimethoxylphenyl)-3-ferrocenyl-3-
phenylsulfonylpropan-1-one (20c)
Yield 92%; orange red solid; mp 182–183 C; 1H NMR
(CDCl3, 500 MHz) d7.26–7.15 (m, 5H), 6.92 (s, 2H), 4.95 (t,
J= 6.5 Hz, 1H), 4.06 (s, 5H), 4.02–4.01 (m, 4H), 3.86 (s,
3H), 3.84 (s, 6H), 3.46 (d, J= 6.5 Hz, 2H). 13C NMR (CDCl3,
125 MHz): 196.91, 154.21, 143.54, 134.35, 132.32, 130.8, 129.1,
127.5, 105.8, 69.84, 68.9, 68.02, 67.73, 67.1, 66.47, 61.0, 56.4,
56.12, 37.64. IR (KBr): 3096, 2927, 2843, 1659, 1489, 1404,
1325, 1131, 1010, 865 cm1. HR-MS (ESIMS) for C28H29-
FeO6S (M+ H)
+ Anal. Calcd 549.1034; found 549.1039.
CHNS: Anal. calcd. for C28H28FeO6S; C, 61.32; H, 5.15; S,
5.85. Found: C, 61.22; H, 5.13; S, 5.91.
2.5.5. 1-(3,4-Dimethylphenyl)-3-ferrocenyl-3-
phenylsulfonylpropan-1-one (21c)
Yield 94%; orange red solid; mp 152–154 C; 1H NMR
(CDCl3, 500 MHz) d 7.84–7.80 (m, 2H), 7.59–7.55 (m, 3H),
7.40 (t, J = 7.5 Hz, 2H), 7.28 (d, J= 8 Hz, 1H), 5.03–5.01
(m, 1H), 4.19–4.10 (m, 4H), 4.09 (s, 5H), 3.85–3.84 (m, 1H),
3.56 (dd, 18 Hz, 4 Hz, 1H), 2.37 (s, 3H), 2.36 (s, 3H). 13C
NMR (CDCl3, 125 MHz): 194.90, 143.42, 137.27, 136.80,
134.13, 133.55, 130.07, 129.47, 129.44, 128.59, 126.05, 81.19,
71.11, 69.18, 68.85, 68.45, 67.32, 61.65, 37.46, 20.14, 19.88.
IR (KBr): 3021, 2910, 2852, 1671, 1441, 1417, 1311, 1142,
1051, 893 cm1. HR-MS (ESIMS) for C27H26FeNaO3S
(M+Na)+ Anal. calcd 509.0850; found 509.0862. CHNS:
Anal. calcd. for C27H26FeO3S; C, 66.67; H, 5.39; S, 6.59.
Found: C, 66.60; H, 5.29; S, 6.72.
2.5.6. 1-Phenyl-3-ferrocenyl-3-(phenylsulfonyl)propan-1-one
(22c)
Yield 94%; orange red solid; mp 133–135 C; 1H NMR
(CDCl3, 500 MHz) d7.52–7.50 (m, 2H), 7.32 (t, J= 8 Hz,
2H), 7.22–7.16 (m, 6H), 4.86 (m, 1H), 4.72–4.70 (m, 2H),
4.45–4.43 (m, 1H), 4.15 (s, 1H), 3.91 (s, 5H), 3.73–3.59 (m,
2H). 13C NMR (CDCl3, 125 MHz):
13C NMR (CDCl3,
125 MHz): 195.54, 144.43, 135.67, 131.73, 130.24, 129.9,
127.64, 127.35, 126.05, 90.05, 68.92, 67.95, 67.46, 67.12,
66.43, 61.3, 37.86. IR (KBr): 3096, 2927, 2843, 1659, 1489,
1404, 1325, 1131, 1010, 865 cm1. HR-MS (ESIMS) for C25-bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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Table 4 Synthesis of ferrocenyl chalcone based sulfone derivatives.
Entry Chalcone Reaction
time (hr)
Yields (%) Sulﬁde Reaction
time (hr)
Yields (%) Sulfone
18 1.5 92 4 92
19 2 91 4 91
20 2.5 93 4 94
21 1 89 4 92
22 1.5 94 4 94
23 2 96 4 94
24 2 96 4.5 95
25 2 95 4 93
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+ Anal. Calcd 459.0717; found 459.0699.
CHNS: Anal. calcd. for C25H22FeO3S; C, 65.51; H, 4.84; S,
7.00. Found: C, 65.49; H, 4.90; S, 7.15.
2.5.7. 1-Ferrocenyl-3-phenyl-3-(phenylsulfonyl)propan-1-one
(23c)
Yield 95%; orange red solid; mp 143–144 C; 1H NMR
(CDCl3, 500 MHz) d 7.43–7.40 (m, 2H), 7.34 (t, J= 8 Hz,
2H), 7.21–7.16 (m, 6H), 4.85 (m, 1H), 4.75–4.72 (m, 2H),
4.46–4.44 (m, 1H), 4.15 (s, 1H), 3.94 (s, 5H), 3.66–3.60 (m,
2H).13C NMR (CDCl3, 125 MHz) d 200.69, 141.67, 135.64,
133.15, 130.41, 129.45, 128.61, 127.64, 127.35, 78.87, 78.01,
77.4, 76.98, 73.44, 72.38, 69.76, 69.42, 69.31, 60.59, 38.83. IR
(KBr): 3096, 2927, 2843, 1659, 1489, 1404, 1325, 1131, 1010,
865 cm1. HR-MS (ESIMS) for C25H23FeO3S (M+ H)
+
Anal. Calcd 459.0717; found 459.0725. CHNS: Anal. calcd.
for C25H22FeO3S; C, 65.51; H, 4.84; S, 7.00. Found: C,
65.55; H, 4.89; S, 7.13.
2.5.8. 1-Ferrocenyl-3-(3,4dimethylphenyl)-3-
(phenylsulfonyl)propan-1-one (24c)
Yield 93%; orange red solid; mp 170–172 C; 1HNMR (CDCl3,
500 MHz) d7.62 (d, J= 8 Hz, 2H), 7.56 (t, 7.5 Hz, 1H), 7.41 (t,
8 Hz, 2H), 7.03 (s, 1H), 7.0–6.96 (m, 2H), 4.86–4.83 (m, 1H),
4.78–4.76 (m, 2H), 4.51–4.50 (m, 2H), 3.99 (s, 5H), 3.67 (m,
2H), 2.17 (s, 3H), 2.16 (s, 3H). 13C NMR (CDCl3, 125 MHz):
198.73, 137.42, 137.32, 136.66, 133.46, 130.88, 129.65, 128.93,
128.60, 127.27, 78.13, 72.50, 69.72, 69.35, 69.05, 65.78, 37.97,
19.65, 19.43. IR (KBr): 3021, 2921, 2852, 1652, 1443, 1400,
1361, 1131, 1038, 881 cm1. HR-MS (ESIMS) for C27H26
FeNaO3S (M+ Na)
+ Anal. calcd 509.0850; found 509.0858.
CHNS: Anal. calcd. for C27H26FeO3S; C, 66.67; H, 5.39; S,
6.59. Found: C, 66.78; H, 5.41; S, 6.71.
3. Results and discussion
3.1. Chemistry
Chalcones were prepared following the literature procedure by
condensation of different acetophenones and aromaticScheme 1 Synthesis of 20-hydroxy, 20-amino chalcone b
Please cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
sulfones. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20aldehydes (Konduru and Ahmed, 2013). The chalcone based
sulﬁdes were synthesized by reacting chalcones with thiophe-
nol in the presence of sodium-metal in dichloromethane at
room temperature via thia Michael addition reaction (Schemes
1–4) (Konduru et al., 2013). Further, the sulﬁdes were oxidized
to sulfones using m-CPBA as oxidizing reagent in dichloro-
methane at 0 C to room temperature in good yields (Schemes
1–4).
Here, we have synthesized different type of chalcone based
sulfone derivatives such as 1–4c (20-hydroxychalcone sulfones),
5–8c (20-aminochalcone sulfones), 9–12c (bis-sulfones), 13–16c
and 17–24c (ferrocenyl sulfones). Monosulfones (1–8c and 13–
24c) and bis-sulfones (9–12c) were synthesized using corre-
sponding sulﬁde and m-CPBA in 1:2.2 and 1:4.5 mol ratio
respectively in an open atmosphere. However, ferrocenyl sulf-
ones (17–24c) were obtained under inert atmosphere (Schemes
3 and 4). During the synthesis of sulfones and bis-sulfones, no
signiﬁcant substituent effects were observed and an excellent
yield (90–98%) was obtained.
The assigned structures of new products (1–8c) were estab-
lished from their spectroscopic data (IR, HRMS, 1H, 13C
NMR). For example, compound 1c was obtained as a white
solid. The IR spectrum of 1c showed absorptions at 3450,
1707 cm1 for OH, carbonyl bond asymmetric stretching and
1315, 1154 cm1 for –SO2– asymmetric, symmetric bond
stretching, respectively. The HRMS of 1c supported a molecu-
lar composition of C22H21O4S (M+H)
+, representing 12 of
unsaturation. In the 1H and 13C NMR spectra, peaks resonat-
ing at dH 2.3 (s, 3H) and dC 21.28 indicate methyl group pres-
ent. Peaks at dH 4.90 (dd, J= 9.5 Hz, 3.5 Hz, 1H), dC 62.94
correspond to CH–SO2 in which vicinal coupling constants
J= 9.5 Hz, and 3.5 Hz indicate methine proton (CH–SO2)
coupled with adjacent protons trans and cis coupling respec-
tively. Peaks at dC 37.22, and dH 4.13 (dd, J= 16 Hz,
3.5 Hz, 1H) correspond to –CH2–CH–SO2, in which coupling
constant J= 16 Hz indicates geminal coupling of methylene
proton (–CH2–CH–SO2) and J= 3.5 Hz indicates vicinal cou-
pling at dH 4.13 and 4.90 protons which conﬁrms the product
formation. Further, shift in dH value of proton (CH–SO2) from
4.56 to 4.90 indicates sulﬁde (1b) conversion to sulfone (1c)
(Table 1).ased sulfones (8c–11c) from corresponding sulﬁdes.
bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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Scheme 2 Synthesis of 1-(4-(methylsulfonyl)phenyl)-3-aryl-3-(phenylsulfonyl)propan-1-one (9c–12c) and synthesis of (E)-3-aryl-1-(4-
(methylsulfonyl)phenyl)prop-2-en-1-one (14c–17c).
Scheme 3 Synthesis of 3-ferrocenyl-1-phenyl chalcone based sulfones (18c–22c).
Scheme 4 Synthesis of 1-ferrocenyl-3-phenyl chalcone based sulfones (23c–24c).
10 N. Ahmed et al.Compound 9c was obtained as a white solid. The IR spec-
trum of 9c showed absorptions at 1653, 1589, 1303, 1057 cm1
for carbonyl bond asymmetric and –SO2– bond asymmetric
and symmetric stretching respectively. The HRMS of 9c sup-
ported a molecular composition of C22H19ClNaO5S2
(M+ Na)+ representing 13 of unsaturation. In the 1H and
13C NMR spectra of 9c, peaks resonating at dH 3.01 (s, 3H)
and dC 44.25 suggested that methyl group attached with -
SO2- group. Peak at dH 4.99 (dd, J= 8.5 Hz, 6 Hz, 1H) corre-
sponds to –CH2-CH–SO2 in which coupling constants
3J= 8.5 Hz, and 6 Hz indicate trans and cis coupling of
methine proton (–CH2-CH–SO2) with adjacent methylene pro-
tons (–CH2-CH–SO2) respectively. Peaks at dH 3.63–3.61 (m,
1H), and 3.59–3.56 (m, 1H) correspond to methylene protons
(–CH2–CH–SO2), which conﬁrms the product formation andPlease cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
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4.99, shift in dH value of methyl proton (CH3–SO2) from 2.5
to 3.01 in sulfone indicates bis-sulﬁde (9b) conversion to bis-
sulfone (9c) (Table 2).
Compound 13c was obtained as a white solid. The IR spec-
trum of 13c showed absorptions at 1726, 1298, 1143 cm1 for
carbonyl asymmetric and –SO2– asymmetric, and symmetric
stretching, respectively. The HRMS of 13c supported a molec-
ular composition of C16H13ClO3NaS (M+Na)
+ representing
10 of unsaturation. In the 1H and 13C NMR spectra of 13c,
peaks resonating at dH 3.03 (s, 3H) and dC 44.36 indicate –
SO2–CH3 group present (Table 3).
Compound 17c was obtained as orange red solid. The IR
spectrum of 17c showed absorptions at 3021, 1108, 1463,
1401 cm1 for ferrocene characteristic stretchings, and 1702,bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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ric, and symmetric stretchings, respectively. The HRMS of 17c
supported a molecular composition of C25H22ClFeO3S
(M+H)+ representing 15 of unsaturation. In the 1H
NMR spectrum peaks at dH 4.19–4.10 (m, 4H), 4.09 (s, 5H)
suggested that mono-substituted ferrocene moiety present. In
the 1H and 13C NMR spectrum peaks at dH 4.98 (t,
J= 6.5 Hz, 1H), dC 66.9, correspond to methine group
(CH–SO2) in which coupling constant
3J= 6.5 Hz indicates
methine proton cis coupling with adjacent methylene protons
(–CH2–CH–SO2). Peaks at dH 3.85, 3.58 correspond to methy-
lene protons (–CH2–CH–SO2), which conﬁrms the product
formation. Further, shift in dH-value from 4.50 to 4.98 and
dC-value from 44.5 to 66.9 of methine group (CH–SO2) in sul-
fone indicates ferrocenyl sulﬁde (13b) conversion to ferrocenyl
sulfone (17c) (Table 4).
3.2. Antimicrobial activity
3.2.1. Microdilution assay
Minimum inhibitory concentration (MIC) values of the com-
pounds against bacterial and fungal isolates were determined
on the basis of micro-well dilution method following NCCLS
recommendations (Zgoda and Porter, 2001). The stock solu-
tion of novel compounds was prepared at a concentration of
10 mg/mL in DMSO, which was further diluted to working
solution of concentration 1 mg/mL solution in methanol.
Using a micropipette, 100 ll of media into all wells of pre-
sterilized 96 well microtiter plate was dispensed (experiment
was done in triplicate). Twofold serial dilutions were made
from the well # 1 to the well # 10 and excess media
(100 ll) was discarded from the last well (# 10). The desired
aliquot was harvested from culture of test organism (log
phase) in corresponding medium (Yeast, Peptone, and D-
Glucose for fungal growth and Luria Bertani Broth, Nutrient
Broth for bacterial growth) for 12–18 h at 37 C. Then opti-
cal density of liquid culture was determined at 600 nm and
diluted in such a way that each well received 104cfu/100 ll
of fungal suspension and 107cfu/100 ll of bacterial culture.
Appropriate positive and negative controls were also
included in the study. Positive control contained only micro-
bial cells where as negative control contained only standard
drug solution (Amphotericin-B and Nystatin for fungus
and Ampicillin and Kanamycin for bacteria). All experimen-
tal procedures were performed under sterile condition using
bio-safety hood and microtiter plates were incubated at
37 C for 12–18 h.
3.2.2. In-vitro antimicrobial activity of novel synthesized
compounds
During antimicrobial screening for novel compounds
(1–24c), yeasts (Aspergillus niger, Candida albicans, Aspergillus
fumigatus, Cryptococcus neoformans, Candida parapsilosis and
Candida tropicalis), Gram positive bacteria (Bacillus subtilis,
Staphylococcus aureus and Listeria monocytogenes) and
Gram negative bacteria (Pseudomonas aeruginosa, Klebseilla
pneumonia, Escherichia coli, Proteus vulgaris) strains were
used. These compounds showed interesting antimicrobial
activity against used strains; particularly the compounds 1c,
6c, 20c, and 24c have shown better antimicrobial activity than
the standard drugs.Please cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
sulfones. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.203.2.3. Antibacterial activity
Compounds 1–24c were evaluated for their antibacterial activ-
ity against Gram positive bacteria (B. subtilis, S. aureus, L.
monocytogenes) and Gram negative bacteria (P. aeruginosa,
K. pneumonia, E. coli, P. vulgaris). The minimum inhibitory
concentration (MIC, lg/mL) was determined by microdilution
method (Jorgensen and Lee, 1975) using Ampicillin and Kana-
mycin as standard drugs and the results are shown in Table 5.
All compounds (1–24c) showed higher antibacterial activity
(3.90–250 lg/mL) compared to reference drug ampicillin (MIC:
250 lg/mL) against B. subtilis. Compounds 6c (MIC: 3.90
lg/mL) and 20c (MIC: 3.90 lg/mL) showed higher and com-
pound 24c (MIC: 7.81 lg/mL) showed equal antibacterial
activity compared to positive control Kanamycin (MIC:
7.81 lg/mL), while remaining compounds showed moderate
to low antibacterial activity against B. subtilis. Against
S. aureus, compounds 1–24c exhibited higher antibacterial
activity (MIC: 1.95–250 lg/mL) with respect to reference drugs
ampicillin (MIC: 500 lg/mL) and kanamycin (MIC: 500
lg/mL). Compounds 4c (MIC: 7.81 lg/mL), 6c (MIC:
1.95 lg/mL) and 20c (MIC: 3.90 lg/mL) showed the highest
antibacterial activity, while the compounds 8c, 10c, 17c, 19c,
21c, 23c, and 24c (MIC: 62.50 lg/mL) showed good antibacte-
rial activity and remaining compounds gave moderate to low
antibacterial activity against S. aureus. Against L. monocytoge-
nes, all compounds exhibited higher antibacterial activity
(MIC: 7–200 lg/mL) compare to standard drug ampicillin
(MIC: 250 lg/mL). However, most of the compounds showed
lower activity than reference drug kanamycin (MIC: 100
lg/mL). Compounds 6c (MIC: 7.81 lg/mL), 20c (MIC:
15 lg/mL) showed highest antibacterial activity and the
remaining compounds showed moderate to low antibacterial
activity against L. monocytogenes. Against P. aeruginosa, com-
pounds 24c (MIC: 1.95 lg/mL), and 21c (MIC: 15.62 lg/mL)
showed highest antibacterial activity, compounds 3c, 6c, 11c,
and 15c (MIC: 31.25 lg/mL) showed good antibacterial activ-
ity, compounds 1c, 8c, 12c, 13c, 16c, and 23c (MIC: 62.50 lg/
mL) showed better antibacterial activity while others showed
moderate antibacterial activity (MICP 125 lg/mL) compared
to standard drugs (ampicillin (MIC: 125 lg/mL), kanamycin
(MIC: 250 lg/mL)). Against K. pneumonia, most of these
compounds showed better antibacterial activity (MIC:
<150 lg/mL) compared to standard drug ampicillin (MIC:
200 lg/mL). Compound 20c (MIC: 1.95 lg/mL) showed high-
est antibacterial activity, compounds 6c (MIC: 25.5 lg/mL),
23c, and 24c (MIC: 31.5 lg/mL) showed good antibacterial
activity, and compounds 11c, 13c, (MIC: <50 lg/mL) showed
moderate antibacterial activity compare to standard drugs
[ampicillin (MIC: 200 lg/mL), kanamycin (MIC: 80 lg/mL)].
Against E. coli, most of the tested compounds showed better
antibacterial activity (MIC:6100 lg/mL) compare to reference
drugs (ampicillin (MIC: 150 lg/mL), kanamycin (MIC: 100
lg/mL)). Compounds 20c (MIC: 10.00 lg/mL), and 24c
(MIC: 3.90 lg/mL) showed the highest antibacterial activity,
compounds 4c, and 6c (MIC: 25.50 lg/mL) showed good anti-
bacterial activity, compounds 21c, 23c (MIC: 50.0 lg/mL), and
3c, (MIC: 55.5 lg/mL) showed moderate antibacterial activity
compare to standard drugs. Against P. vulgaris, most of these
compounds showed equal to higher antibacterial activity
(MIC: 25–250 lg/mL) compare to reference drugs
[ampicillin (MIC: 200 lg/mL), kanamycin (MIC: 125 lg/bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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Table 5 Minimum inhibitory concentration (MIC) in lg/mL of chalcone based sulfone derivatives against bacterial strains evaluated
by micro-dilution method.
Entry Drug Gram positive bacteria Gram negative bacteria
B. subtilis
(lg/mL)
S. aureus
(lg/mL)
L. monocytogenes
(lg/mL)
P. aeruginosa
(lg/mL)
K. pneumonia
(lg/mL)
E. coli
(lg/mL)
P. vulgaris
(lg/mL)
1 Ampicillin 250 500 250 125 200 150 200
2 Kanamycin 7.81 500 100 250 50 100 125
3 1c 62.50 125 150 62.50 80.0 100 150
4 2c 125 125 150 250 100 125 200
5 3c 125 125 150 31.25 125 55.5 150
6 4c 62.50 7.81 150 62.50 80.0 25.5 150
7 5c 125 250 200 250 250 200 250
8 6c 3.90 1.95 7.81 31.25 25.5 25.5 30.50
9 7c 250 250 200 250 150 200 150
10 8c 125 62.50 100 62.50 150 80.0 80.0
11 9c 125 125 150 125 150 200 150
12 10c 62.50 62.50 125 250 80.0 100 125
13 11c 62.50 125 100 31.25 50.0 70.0 100
14 12c 125 125 200 62.50 100 125 150
15 13c 62.50 125 100 62.50 48.5 80.0 100
16 14c 62.50 125 150 125 100 150 150
17 15c 125 250 100 31.25 125 250 30.50
18 16c 125 125 100 62.50 100 100 70.0
19 17c 125 62.50 100 125 150 150 150
20 18c 125 250 250 250 150 200 200
21 19c 62.50 62.50 200 125 80.0 80.0 100
22 20c 3.90 3.90 15.0 250 1.95 10.0 25.0
23 21c 125 62.50 125 15.62 100 50.0 70.0
24 22c 125 125 150 125 150 125 125
25 23c 125 62.50 100 62.50 31.5 50.0 80.0
26 24c 7.81 62.50 150 1.95 31.5 3.90 25.0
Bold values indicate better highlights.
12 N. Ahmed et al.mL)]. Compounds 20c, 24c (MIC: 25.00 lg/mL), 6c, and 15c
(MIC: 30.50 lg/mL) showed highest antibacterial activity,
compounds 16c, 21c (MIC: 70.00 lg/mL), 8c, and 23c (MIC:
80.00 lg/mL) showed moderate antibacterial activity, the
remaining compounds showed lower activity compare to refer-
ence drugs. Compounds 6c and 20c gave the highest antibacte-
rial activity against almost all tested bacterial strains (Table 5).
The antibacterial activity of chalcone based sulfones and
bis-sulfones showed the substituents effect on chalcone nuclei.0 
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0-hydroxychal-
cone based sulfones (4c) has enhanced antibacterial activity
against S. aureus than the other substituents like 4-methyl, 4-
Chloro, and 3,4,5-trimethoxy containing compounds. In the
case of 20-aminochalcone based sulfones (5–8c), 4-Chloro
substituted on B ring (compound 6c) has enhanced antibacte-
rial activity against S. aureus than the other substituents like 4-
methyl, 3-nitro containing compounds. In bis sulfones (9–12c),
4-methyl substituted on B ring (compound 11c) has enhanced16
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‘‘Activities of novel ferrocenyl and chalcone based sulfones and bis-sulfones’’ 13antibacterial activity against P. aruginosa than the other sub-
stituents like 4-Chloro, 3-NO2 containing compounds. In ferr-
ocenyl chalcone based sulfones (17–24c), 3,4,5-trimethoxy
substituted on A ring (compound 20c) and 3,4-dimethyl substi-
tuted on B ring (compound 24c) have enhanced antibacterial
activity against almost tested stains. Compound 24c showed
4-folds active against B. subtilis, compounds 4c, 6c and 20c
showed 8-, 32-, 16-folds active against S. aureus respectively.
Compounds 1c, 4c, 8c, 12c, 13c, 16c and 23c showed 2-folds
active, compounds 3c, 6c, 11c and 15c showed 4-folds active
and compounds 21c and 24c showed 8- and 64-folds active0 
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Table 6 Minimum inhibitory concentration (MIC) in lg/mL of chal
dilution method.
Entry Drug A. niger
(lg/mL)
C. albicans
(lg/mL)
A. fu
(lg/m
1 Nystatin 500 15.62 500
2 Amphotericin B 7.81 7.81 5.65
3 1c 62.50 62.50 67.25
4 2c 31.25 62.50 30.50
5 3c 125 62.50 95.0
6 4c 62.50 62.50 100.0
7 5c 62.50 250 100
8 6c 62.50 31.25 25.5
9 7c 125 62.50 31.5
10 8c 125 62.50 100
11 9c 125 62.50 70
12 10c 62.50 125 100
13 11c 125 250 125
14 12c 125 125 125
15 13c 250 62.50 100
16 14c 125 62.50 100
17 15c 125 125 200
18 16c 125 125 200
19 17c 125 250 200
20 18c 250 250 150
21 19c 62.50 62.50 70.0
22 20c 125 250 125
23 21c 125 125 125
24 22c 125 125 125
25 23c 125 250 150
26 24c 3.90 7.81 10.5
Bold values indicate better highlights.
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(Simpkins, 1993). Comparative analysis of antibacterial activ-
ity (Gram positive and negative bacteria) of novel compounds
with respect to reference drugs is shown in Figs. 2 and 3.
3.2.4. Antifungal activity
Novel synthesized compounds (1–24c) were further evaluated
for their antifungal activity against A. niger, C. albicans, A.
fumigatus, C. neoformans, C. parapsilosis and C. tropicalis
pathogens. The minimum inhibitory concentration (MIC,
lg/mL) was determined by microdilution method (Jorgensen13
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migatus
L)
C. neoformans
(lg/mL)
C. parapsilosis
(lg/mL)
C. tropicalis
(lg/mL)
200 25.0 10.0
5.75 4.5 8.50
75.5 80.0 80.0
40.5 35.5 25.5
50.0 75.5 15.5
45.5 45.5 70.0
75.0 75.0 75.0
35.5 65.5 80.0
50.0 25 25
65 50 40
70 80 25.5
70 80 100
200 150 150
200 200 100
80.0 100 150
125 125 100
125 125 100
125 125 100
150 100 150
150 200 200
70.0 50.0 45.5
100 100 150
150 100 100
100 100 125
125 100 100
3.90 7.81 15.5
bial activities of novel ferrocenyl and organic chalcone based sulfones and bis-
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14 N. Ahmed et al.and Lee, 1975; Zgoda and Porter, 2001) using Amphotericin-B
and Nystatin as standard drugs and the results are shown in
Table 6.
All compounds (1–24c) showed higher antifungal activity
(3.90–125 lg/mL) compare to reference drug Nystatin (MIC:
500 lg/mL) against A. niger. However, most of these com-
pounds showed lower antifungal activity than the reference
drug Amphotericin B (MIC: 7.81 lg/mL). Compounds 24c
(MIC: 3.90 lg/mL) and 2c (MIC: 31.25 lg/mL) showed higher
and compounds 1c, 4c, 5c, 6c, 10c and 19c (MIC: 62.5 lg/mL)
showed moderate while the remaining compounds showed
lower antifungal activity against A. niger. Against C. albicans,
all compounds exhibited moderate antifungal activity (MIC:
7.81–250 lg/mL) compare to reference drugs Nystatin (MIC:
15.62 lg/mL) and Amphotericin B (MIC: 7.81 lg/mL). Com-
pound 24c (MIC: 7.81 lg/mL) showed the highest antifungal
activity, compound 6c (MIC: 31.25 lg/mL) showed good anti-
fungal activity and the remaining compounds showed lower
antifungal activity compare to reference drugs. Against A.
fumigatus, all compounds exhibited higher antifungal activity
(MIC: 10.5–100 lg/mL) compare to reference drug Nystatin
(MIC: 500 lg/mL), but lower antifungal activity than reference
drug Amphotericin B (MIC: 5.65 lg/mL). Compound 24c0 
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Figure 5 Venn diagram of microbial activ
Please cite this article in press as: Ahmed, N. et al., Design, synthesis and antimicro
sulfones. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.20(MIC: 10.5 lg/mL) showed highest antifungal activity, com-
pounds 2c (MIC: 30.5 lg/mL), 6c (MIC: 25.5 lg/mL), and 7c
(MIC: 31.5 lg/mL) showed good antifungal activity and the
remaining compounds showed moderate to low antifungal
activity compare to reference drugs against A. fumigatus.
Against C. neoformans, all compounds exhibited higher anti-
fungal activity (MIC: 3.90–200 lg/mL) compare to reference
drug Nystatin (MIC: 200 lg/mL), but lower antifungal activity
compare to reference drug Amphotericin B (MIC: 5.75
lg/mL). Compound 24c (MIC: 3.90 lg/mL) showed the high-
est antifungal activity, compounds 2c (MIC: 40.5 lg/mL), 3c
(MIC: 50.0 lg/mL), 4c (MIC: 45.5 lg/mL), 6c (MIC:
35.5 lg/mL), and 7c (MIC: 50.0 lg/mL) showed good anti-
fungal activity while all other compounds showed moderate
to low antifungal activity compare to reference drugs. Against
C. parapsilosis, all compounds exhibited moderate antifungal
activity (MIC: 7.81–80 lg/mL) compare to reference drugs
Nystatin (MIC: 25.0 lg/mL) and Amphotericin B (MIC:
4.5 lg/mL). Compound 24c (MIC: 7.81 lg/mL) showed high
antifungal activity compare to reference drugs. Against C.
tropicalis, all compounds exhibited low antifungal activity
(MIC: 15.5–200 lg/mL) compare to reference drugs Nystatin
(MIC: 10.0 lg/mL) and Amphotericin B (MIC: 8.5 lg/mL).13
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‘‘Activities of novel ferrocenyl and chalcone based sulfones and bis-sulfones’’ 15Compounds 3c and 24c (MIC: 15.5 lg/mL) showed high anti-
fungal activity and compounds 2c, 9c (MIC: 25.5 lg/mL) and
7c (MIC: 25 lg/mL) showed moderate antifungal activity
(Table 6).
The antifungal activity of chalcone based sulfones and bis-
sulfones showed the substituents effect on chalcone nuclei. For
example, 4-chloro substituted on B ring of 20-hydroxychalcone
based sulfones (2c) has enhanced antifungal activity against
tested fungi pathogens than 4-methyl, 3-NO2, 3,4,5-trimethoxy
containing compounds. In the case of 20-aminochalcone based
sulfones (5–8c), 4-chloro substituted on B ring (compound 6c)
has enhanced antifungal activity against A. niger, C. albicans,
A. fumigatus, and C. neoformans and compound 7c (no
substitution) showed enhanced antifungal activity against
C. neoformans, C. parapsilosis, and C. tropicalis. In ferrocenyl
chalcone based sulfones (17–24c), 3,4-dimethyl substituted on
B ring (compound 24c) has 2-folds enhanced antifungal activ-
ity against tested stains from previous results (Simpkins, 1993).
Comparative analysis of antifungal activity of novel synthe-
sized compounds with respect to reference drugs is shown in
Fig. 4. A Venn diagram is shown for all compounds which
are active against Gram positive and negative bacteria and
fungi in Fig. 5.
4. Conclusion
In conclusion, we have synthesized new class of ferrocenyl and
organic chalcone based sulfones and bis-sulfones and evalu-
ated their antibacterial and antifungal activities. The majority
of the compounds have higher inhibitory activity against
bacteria than the fungi. Compounds 6c, 20c, and 24c
demonstrated the highest antibacterial activity against all
Gram-positive and negative bacteria. Compound 24c showed
higher antifungal activity against tested pathogens and the
highest antifungal activity against A. niger, C. parapsilosis than
the reference drugs nystatin and amphotericin B. Other sulfone
derivatives showed fair to low antibacterial and antifungal
activities. The antibacterial and antifungal activities of
chalcone based sulfones and bis-sulfones also showed the
substituents effect on chalcone nuclei. 3-NO2 substituted
20-hydroxychalcone sulfones, 4-chloro substituted 20-aminoch-
alcone sulfones, 3,4,5-trimethoxy and 3,4-dimethyl substituted
ferrocenyl chalcone sulfones showed excellent antimicrobial
activity. The order of antimicrobial activity in tested com-
pounds: ferrocenyl chalcone sulfones > 20-hydroxychalcone
sulfones > 20-aminochalcone sulfones > bis-sulfones.Acknowledgments
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